Aptar Reports Third Quarter 2026 Results. Learn more: ow.ly/sMac5102hBI
Aptar today announced that its Board of Directors declared a quarterly cash dividend of $0.50 per share. Learn more: ow.ly/3qbu5102he5
Thank you to @CrainsChicago for highlighting Virginie Maes’ appointment to Aptar Pharma President, effective January 1, 2027.
Aptar taps packaging executive to run pharma business chicagobusiness.com/health-c…
Aptar Pharma announces a collaboration with Stevanato Group, combining glass syringes & elastomer components to provide system-level data earlier in development & help inform packaging decisions for injectable therapies. ow.ly/XNLT5101gR5 #AptarPharma #Injectables
Aptar Pharma acquires PULMOTREE, expanding growth opportunities in next-generation #pulmonary #drugdelivery. The acquisition is expected to accelerate development and commercialization of the Kolibri™ Non-Propellant Liquid Inhaler. Full Press Release: ow.ly/POfG5101b2r
Join Aptar Pharma’s David Farrow on 2 Nov for a webinar exploring how molecular understanding, predictive science and in silico modelling can help inform formulation strategy for inhaled biologics. Register for one of two sessions: ow.ly/IqLA5100zRg
We are pleased to share that Virginie Maes has been appointed as President of Aptar Pharma, effective January 1, 2027.
To learn more about the appointment, please visit our newsroom: ow.ly/W9QC5100kwi
Can the nose provide a direct pathway to the brain? Aptar Pharma and Dianosic discuss their collaboration, upcoming Phase I studies, and the future potential of Nose-to-Brain drug delivery. Watch our video interview: ▶️ow.ly/JZWH50ZTLcc #AptarPharma #Dianosic #NoseToBrain
Heading to #PODD2026? Don't miss Reenal Gandhi's presentation on Oct. 29 exploring the opportunities and challenges of intranasal delivery for CNS therapeutics. Connect with #AptarPharma to discuss the future of #drugdelivery. #NasalDrugDelivery
Some highlights from three fantastic days at #CPHIMilan last week. A big thank you to everyone who stopped by, connected with our teams and made this year’s event such a great one. See you next year!
#CPHIMilan #AptarPharma #DrugDelivery
Heading to #WorldVaccineCongress next week? Meet the #AptarPharma team to talk nasal vaccine delivery. And don’t miss our talk on critical considerations in nasal vaccine development, Oct. 21 at 11:15 AM. See you there! #DrugDelivery #NasalVaccines
Aptar Pharma’s LuerVax® intranasal delivery device & accompanying Spray Divider have been CE marked under the EU Medical Device Regulation (MDR). This milestone expands support for customers developing innovative intranasal vaccine products. ow.ly/jtzh50ZXPFm
#NasalVaccines
How can drug manufacturers gain an earlier, more complete view of assembled-system performance? Join #AptarPharma & Stevanato Group Oct 27 for a webinar exploring a USP <382>-aligned, system-level approach. Session 1: ow.ly/HU2A50ZX0Ka Session 2: ow.ly/a4z650ZX0Kb
Congratulations to our Board director, Dr. Julie Xing, on being recognized by Fortune as one of the Most Powerful Women in Asia. We’re proud to see Julie recognized among these influential leaders and celebrate the global perspective she brings to Aptar. ow.ly/liXu50ZWRw6
Thanks to everyone who joined us at #CPHIMilan this week. It was a pleasure connecting with customers, partners & industry peers & sharing how #AptarPharma is helping advance #drugdelivery. Special thanks to our entire team for making this year's event such a success. Ciao!
Earlier this week, we hosted a ribbon cutting ceremony to celebrate our expanded operations in Mumbai. The site now offers local molding and manufacturing capabilities for pMDI valves, breath-actuated systems and multidose nasal spray systems.
Learn more: ow.ly/sBWf50ZW4Wn
Day 3 is underway at #CPHIMilan! Thanks to everyone who joined our talk yesterday on the future of #nasaldrugdelivery. If you are attending CPHI today, visit Booth 11A43 to meet the #AptarPharma team to learn how we support customers from formulation to patient. #DrugDelivery
Today on #WorldSightDay, we recognize the importance of accessible eye care for all. At #AptarPharma, we're committed to advancing eye health through patient-focused innovation & reliable #drugdelivery solutions. Because every person's sight matters. #Eyecare
At #PDAPFS visit Booth 411 to discover #AptarPharma’s newly launched Premia™ Precision, a new quality standard for injectables & how Noble combines human factors, training, onboarding & engagement to help turn innovative #drugdelivery systems into better patient experiences.
Day 2 at #CPHIMilan is well underway! Meet our team at Booth 11A43 to find out why customers choose to partner with #AptarPharma. And don’t miss our talk at 14:15 today at area 11A49, discussing how patient needs are shaping the evolution of #nasaldrugdelivery. #DrugDelivery
